Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Operating Leases (2023 - 2024)

Fennec Pharmaceuticals' Operating Leases history spans 2 years, with the latest figure at $2000.0 for Q4 2024.

  • For the quarter ending Q4 2024, Operating Leases changed 0.0% year-over-year to $2000.0, compared with a TTM value of $2000.0 through Dec 2024, changed 0.0%, and an annual FY2024 reading of $2000.0, changed 0.0% over the prior year.
  • Operating Leases for Q4 2024 was $2000.0 at Fennec Pharmaceuticals, down from $7000.0 in the prior quarter.
  • The five-year high for Operating Leases was $17000.0 in Q1 2024, with the low at $2000.0 in Q4 2023.